Resistance or intolerance to prior therapy
Drug | Drug Name | Drug Description |
---|---|---|
DB00307 | Bexarotene | A retinoid drug used for cutaneous manifestations of T-cell lymphoma in patients who have not responded well to previous systemic therapy. |
DB06616 | Bosutinib | An antineoplastic agent used for the treatment of chronic, accelerated, or blast phase Philadelphia chromosome-positive (Ph+) chronic myelogenous leukemia (CML) in adults with inadequate clinical response to other treatments. |
DB01254 | Dasatinib | A tyrosine kinase inhibitor used for the treatment of Philadelphia chromosome-positive acute lymphoblastic leukemia or chronic myeloid leukemia. |
DB00997 | Doxorubicin | A medication used to treat various cancers, including AIDS-associated Kaposi's Sarcoma and metastatic cancers. |
DB15569 | Sotorasib | An experimental KRAS inhibitor being investigated for the treatment of KRAS G12C mutant non small cell lung cancer, colorectal cancer, and appendix cancer. |
Drug | Drug Name | Phase | Status | Count |
---|